Adlai Nortye Group Ltd. (ANL) Stock
Healthcare · Biotechnology · Member of Other US Stocks
Adlai Nortye Group Ltd. (ANL) closed at USD 10.88 on 2026-10-14, a change of +620.5 % over the past year, with a market capitalization of USD 778.57M.
Adlai Nortye Group Ltd. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 10.88 |
| 2026-10-13 | 11.76 |
| 2026-10-12 | 14.22 |
| 2026-10-09 | 15.62 |
| 2026-10-08 | 15.51 |
| 2026-10-07 | 14.05 |
| 2026-10-06 | 14.46 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Adlai Nortye Group Ltd. key figures
- Previous close
- USD 10.88 (2026-10-14)
- 1-year change
- +620.5 %
- Market cap
- USD 778.57M
- Enterprise value
- USD 572.46M
- P/E ratio (trailing)
- -19.82
- P/E ratio (forward)
- -41.08
- EPS (trailing)
- -0.61
- EPS (forward)
- -0.29
- PEG ratio
- n/a
- Price to book
- 3.62
- Revenue growth
- n/a
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 28.04
- Employees
- 109
- Analyst consensus (third-party)
- strong_buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Adlai Nortye Group Ltd.
Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies. Its RAS-targeting programs include AN9025, an oral pan-RAS(ON) inhibitor for RAS-driven cancers, and AN4035, a CEACAM5-targeting antibody-drug conjugate that delivers a pan-RAS(ON) inhibitor to tumors. Its immunotherapy programs include AN8025, a tri-functional fusion protein (aPD-L1 x CD86 variant x LAG3 variant) that modulates T-cells and antigen-presenting cells; AN0025, a small molecule EP4 antagonist; and AN4005, an oral small-molecule PD-L1 inhibitor. The company supports its pipeline through an immuno-oncology research and development platform with operations in the United States and China. Adlai Nortye Group Ltd. was formerly known as Adlai Nortye Ltd. and changed its name to Adlai Nortye Group Ltd. in July, 2026. Adlai Nortye Group Ltd. was founded in 2004 and is based in Singapore.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Adlai Nortye Group Ltd. and compare it with other stocks.
Analyze ANLAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Adlai Nortye Group Ltd. shares.